Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Teratoma 1Neoplasms, Germ Cell and Embryonal 1Endodermal Sinus Tumor 1Carcinoma, Embryonal 1

Interventions

Carboplatin 129pembrolizumab 124Cisplatin 114Paclitaxel 103Gemcitabine 84Specimen Handling 81Magnetic Resonance Spectroscopy 81Docetaxel 71Dexamethasone 61Cyclophosphamide 61Pemetrexed 55Bevacizumab 55durvalumab 53Doxorubicin 53Radiotherapy 50Radiation 49Capecitabine 48Oxaliplatin 47Fluorouracil 47Vincristine 43Rituximab 43Leucovorin 42Lenalidomide 40Nivolumab 38Etoposide 38atezolizumab 35Letrozole 35Prednisone 32Bortezomib 32Irinotecan 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Respiratory Physiological Phenomena × 90 days × Clear all
NCT03067181 2026-05-05

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

Children's Oncology Group

Phase 3 Recruiting
1,780 enrolled

Neoplasms, Germ Cell and Embryonal, Teratoma, Carcinoma, Embryonal, Endodermal Sinus Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡